CCL21 and non-small cell lung carcinoma: Based on extensive pre-clinical evaluation, we began an NCI funded clinical trial one year ago assessing the intratumoral injection of DC transduced with an adenoviral vector expressing the CCL21 gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC) [21].